These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39118304)

  • 1. A defective splicing machinery promotes senescence through MDM4 alternative splicing.
    Deschênes M; Durand M; Olivier MA; Pellerin-Viger A; Rodier F; Chabot B
    Aging Cell; 2024 Nov; 23(11):e14301. PubMed ID: 39118304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA.
    Yano K; Takahashi RU; Shiotani B; Abe J; Shidooka T; Sudo Y; Yamamoto Y; Kan S; Sakagami H; Tahara H
    J Biol Chem; 2021 Jul; 297(1):100882. PubMed ID: 34144037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.
    Lagisetti C; Yermolina MV; Sharma LK; Palacios G; Prigaro BJ; Webb TR
    ACS Chem Biol; 2014 Mar; 9(3):643-8. PubMed ID: 24377313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
    Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
    Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery.
    Bezzi M; Teo SX; Muller J; Mok WC; Sahu SK; Vardy LA; Bonday ZQ; Guccione E
    Genes Dev; 2013 Sep; 27(17):1903-16. PubMed ID: 24013503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4.
    Weinstein HNW; Hu K; Fish L; Chen YA; Allegakoen P; Pham JH; Hui KSF; Chang CH; Tutar M; Benitez-Rivera L; Baco MB; Song H; Giacomelli AO; Vazquez F; Ghandi M; Goodarzi H; Huang FW
    Cell Rep; 2024 Aug; 43(8):114622. PubMed ID: 39146182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
    Jacob AG; O'Brien D; Singh RK; Comiskey DF; Littleton RM; Mohammad F; Gladman JT; Widmann MC; Jeyaraj SC; Bolinger C; Anderson JR; Barkauskas DA; Boris-Lawrie K; Chandler DS
    Neoplasia; 2013 Sep; 15(9):1049-63. PubMed ID: 24027430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ribosomal protein L22 binds the MDM4 pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress.
    Jansen J; Bohnsack KE; Böhlken-Fascher S; Bohnsack MT; Dobbelstein M
    Cell Rep; 2024 Aug; 43(8):114610. PubMed ID: 39116201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herboxidiene triggers splicing repression and abiotic stress responses in plants.
    AlShareef S; Ling Y; Butt H; Mariappan KG; Benhamed M; Mahfouz MM
    BMC Genomics; 2017 Mar; 18(1):260. PubMed ID: 28347276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.
    Anufrieva KS; Shender VО; Arapidi GP; Pavlyukov MS; Shakhparonov MI; Shnaider PV; Butenko IO; Lagarkova MA; Govorun VM
    Genome Med; 2018 Jun; 10(1):49. PubMed ID: 29950180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 and MDM4 splicing: an integral part of the cancer spliceome.
    Jeyaraj S; O'Brien DM; Chandler DS
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2647-56. PubMed ID: 19273224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.
    Pavlyukov MS; Yu H; Bastola S; Minata M; Shender VO; Lee Y; Zhang S; Wang J; Komarova S; Wang J; Yamaguchi S; Alsheikh HA; Shi J; Chen D; Mohyeldin A; Kim SH; Shin YJ; Anufrieva K; Evtushenko EG; Antipova NV; Arapidi GP; Govorun V; Pestov NB; Shakhparonov MI; Lee LJ; Nam DH; Nakano I
    Cancer Cell; 2018 Jul; 34(1):119-135.e10. PubMed ID: 29937354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and expression of a novel MDM4 splice variant in human glioma.
    Wang X; Sheng P; Guo X; Wang J; Hou L; Hu G; Luo C; Dong Y; Lu Y
    Brain Res; 2013 Nov; 1537():260-6. PubMed ID: 23994448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.
    Gerhart SV; Kellner WA; Thompson C; Pappalardi MB; Zhang XP; Montes de Oca R; Penebre E; Duncan K; Boriack-Sjodin A; Le B; Majer C; McCabe MT; Carpenter C; Johnson N; Kruger RG; Barbash O
    Sci Rep; 2018 Jun; 8(1):9711. PubMed ID: 29946150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia.
    Liu L; Fan L; Fang C; Zou ZJ; Yang S; Zhang LN; Li JY; Xu W
    Cancer Sci; 2012 Dec; 103(12):2056-63. PubMed ID: 22937789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
    Teng T; Tsai JH; Puyang X; Seiler M; Peng S; Prajapati S; Aird D; Buonamici S; Caleb B; Chan B; Corson L; Feala J; Fekkes P; Gerard B; Karr C; Korpal M; Liu X; T Lowe J; Mizui Y; Palacino J; Park E; Smith PG; Subramanian V; Wu ZJ; Zou J; Yu L; Chicas A; Warmuth M; Larsen N; Zhu P
    Nat Commun; 2017 May; 8():15522. PubMed ID: 28541300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
    Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
    Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.
    Naro C; Antonioni A; Medici V; Caggiano C; Jolly A; de la Grange P; Bielli P; Paronetto MP; Sette C
    J Exp Clin Cancer Res; 2024 Feb; 43(1):58. PubMed ID: 38413979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Inhibition of Pre-mRNA Splicing in Living Saccharomyces cerevisiae.
    Hansen SR; Nikolai BJ; Spreacker PJ; Carrocci TJ; Hoskins AA
    Cell Chem Biol; 2019 Mar; 26(3):443-448.e3. PubMed ID: 30639260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
    Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
    Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.